1. |
Does microchimerism induce graft tolerance? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1087,
1997,
Page 2-2
&NA;,
Preview
|
PDF (1166KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
2. |
News in brief… |
|
Inpharma Weekly,
Volume &NA;,
Issue 1087,
1997,
Page 3-3
&NA;,
Preview
|
PDF (982KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
3. |
Mercaptamine reduces costs in infantile cystinosis |
|
Inpharma Weekly,
Volume &NA;,
Issue 1087,
1997,
Page 4-4
&NA;,
Preview
|
PDF (1040KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
4. |
News in brief… |
|
Inpharma Weekly,
Volume &NA;,
Issue 1087,
1997,
Page 5-5
&NA;,
Preview
|
PDF (1012KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
5. |
News in brief… |
|
Inpharma Weekly,
Volume &NA;,
Issue 1087,
1997,
Page 6-6
&NA;,
Preview
|
PDF (1079KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
6. |
New methods to inhibit LPS in sepsis |
|
Inpharma Weekly,
Volume &NA;,
Issue 1087,
1997,
Page 7-8
Gill Higgins,
Preview
|
PDF (2248KB)
|
|
摘要:
The lipid A antagonist E-5531 is the first agent that has been shown to block or ameliorate all the effects of bacterial lipopolysaccharide [LPS] endotoxin in a human endotoxin challenge model, according to study results presented at the 7th International IBC Conference on Sepsis [Washington DC, US; April 1997]. Treatment with E-5531 was one of 3 new methods of neutralising the effects of LPS in Gram-negative sepsis that were presented at the conference. The other approaches discussed were the use of the lipid A biosynthesis inhibitor L-573655 and its analogues, and the administration of reconstituted HDL-cholesterol for clearing LPS from the circulation. According to leading researchers in the field, blocking the effects of LPS may be the key to reducing mortality and morbidity rates in sepsis.
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
7. |
Gene therapy produces renal cancer vaccine |
|
Inpharma Weekly,
Volume &NA;,
Issue 1087,
1997,
Page 9-9
&NA;,
Preview
|
PDF (1016KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
8. |
Dual-release levodopa/benserazide promising for Parkinson's |
|
Inpharma Weekly,
Volume &NA;,
Issue 1087,
1997,
Page 10-10
&NA;,
Preview
|
PDF (1087KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
9. |
Treat douche-related bacterial vaginosis to avoid complications |
|
Inpharma Weekly,
Volume &NA;,
Issue 1087,
1997,
Page 11-12
Larry Prescott,
Preview
|
PDF (2141KB)
|
|
摘要:
In a number of recent reports, both published and unpublished, the practice of vaginal douching for hygiene purposes has been shown to be unnecessary and even harmful, as it can lead to bacterial vaginosis or recurrent yeast vaginitis. During a round table discussion, the relationship between douching and the development of bacterial vaginosis, the consequences of bacterial vaginosis, and the steps that can be taken for diagnosis, treatment, and, most importantly, prevention of this disorder were discussed by experts at the 45th Annual Clinical Meeting of the American College of Obstetricians and Gynaecologists [Las Vegas, US; April 1997].
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
10. |
Comparing fluticasone and/or salmeterol in nocturnal asthma |
|
Inpharma Weekly,
Volume &NA;,
Issue 1087,
1997,
Page 12-12
&NA;,
Preview
|
PDF (1104KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|